用FOLFOX化疗治疗的不可切除的初级肠类胸腺癌:一个病例报告
Carl He1, Georgia Bentick1,2, Patrick Hosking3
1Department of Oncology, Eastern Health, Melbourne, Australia.
Cancer reports (Hoboken, N.J.)
|September 4, 2025
概括
这项案例研究突出显示了澳大利亚首次使用FOLFOX化疗来治疗不可切除的肠类胸腺癌. 这种以胃肠道为灵感的治疗方法有望减少瘤,
科学领域:
- 癌症学
- 病理学
- 医学成像
背景情况:
- 肠道型胸膜腺癌是一种极为罕见的胸膜恶性瘤,与胃肠癌具有共同的特征.
- 对于这种特定的亚型,没有确定的治疗指南.
- 2021年世界卫生组织的分类认可这一独特实体.
研究的目的:
- 报告澳大利亚首例肠道型胸腺癌.
- 作为一线治疗方法,记录氧利/5-甲/白血素 (FOLFOX) 化疗的疗效.
- 探索胃肠癌治疗方案的潜力,
主要方法:
- 一位65岁的女性患有无法切除的前半胸腺瘤,
- 免疫组织化学证实了肠道型胸腺癌 (CK20+,CDX2+,CD5+,CK7+).
- 患者接受了缓解性放射治疗,随后进行了四次FOLFOX化疗.
主要成果:
- 在FOLFOX化疗后,前半质体大小显著减少.
- 在治疗停止后的六个月内观察到疾病的稳定性.
- 患者在诊断后存活了13个月.
结论:
- 对于不可切除的肠类胸腺癌,FOLFOX是一种可行的,可能有效的前线全身疗法.
- 与胃肠道恶性瘤的分子相似性支持使用类似的化疗方案.
- 这一案例凸显了针对罕见的胸膜瘤进行进一步研究的必要性.
更多相关视频
相关概念视频
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Tumor Immunotherapy
658
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
658


